FTO is shown to be abnormally regulated in t (11q23)/MLL-rearranged, t (15;17)/PML::RARA, FLT3-ITD, and/or NPM1-mutated AML phenotypes. The gene discussed is KMT2A; the disease is acute myeloid leukemia.